A. Poveda

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 465 citations

Medicine, Cancer Management, Reproductive Health +9

Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel

Paul Hoskins, Ignace Vergote, Andrés Cervantes et al. · JNCI Journal of the National Cancer Institute · 2010 · 90 citations · Full text

A randomized phase II (RP2) trial of ridaforolimus (R) compared with progestin (P) or chemotheraphy (C) in female adult patients with advanced endometrial carcinoma.

Amit M. Oza, A. Poveda, A. Clamp et al. · Journal of Clinical Oncology · 2011 · 35 citations

Cancer Management, Gynecology, Pharmacotherapy +17

First Results of a Randomised Trial Comparing Radiotherapy Versus- Observation Post Operatively in Patients With Uterine Sarcomas. An EORTC-GCG Study

Nicholas S. Reed, Costantino Mangioni, Henric Malmström et al. · International Journal of Gynecological Cancer · 2003 · 26 citations

Radiation Therapy, An Eortc-gcg Study, Medicine +7

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

Lori A. Brotto, Michael Brundage, Paul Hoskins et al. · Supportive Care in Cancer · 2015 · 20 citations

Oncology, Medicine, Cancer Management +3